3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
87
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Recurrence
16
Burkitt Lymphoma
13
Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Immunoglobulin Light-chain Amyloidosis
6
Neoplasms, Plasma Cell
5
Hodgkin Disease
5
Smoldering Multiple Myeloma
4
Leukemia
4
Carcinoma, Non-Small-Cell Lung
4
Waldenstrom Macroglobulinemia
3
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Nausea
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Brain Neoplasms
3
Renal Insufficiency
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell
2
Leukemia, Plasma Cell
2
Interventions
Radiotherapy
7
Heavy Ion Radiotherapy
3
Radiosurgery
2
Proton Therapy
2
Chemoradiotherapy
2
Blood Specimen Collection
2
sodium propionate
1
lithium sulfate
1
Xylitol
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Patient Reported Outcome Measures
1
Neuropsychological Tests
1
Lymph Node Excision
1
Lithium
1
Lisinopril
1
Fatty Acids, Volatile
1
Etoposide
1
Dexamethasone
1
Consolidation Chemotherapy
1
Cisplatin
1
Carboplatin
1
Butyric Acid
1
Bevacizumab
1
Betaine
1
Base Sequence
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Radiation Injuries
×
Dexamethasone
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled